Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Axonics, Inc. (AXNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
73.74+1.36 (+1.88%)
At close: 04:00PM EDT
73.70 -0.04 (-0.05%)
After hours: 06:58PM EDT
Advertisement

Axonics, Inc.

26 Technology Drive
Irvine, CA 92618
United States
949 396 6322
https://www.axonics.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees517

Key Executives

NameTitlePayExercisedYear Born
Mr. Raymond W. CohenCEO & Director1.34MN/A1959
Mr. Danny L. DearenPres & CFO790.2k3.69M1963
Mr. Rinda K. SamaChief Operating Officer758.6k736.11k1980
Dr. John Woock Ph.D.Exec. VP, Chief Marketing & Strategy Officer586.35k599.57k1984
Mr. Alfred J. Ford Jr.Chief Commercial Officer585.99k2.24M1971
Mr. Guangqiang Jiang Ph.D.Chief Technology OfficerN/AN/A1974
Mr. Neil BhalodkarVP of Investor RelationsN/AN/AN/A
Mr. Aaron PettitGen. Counsel & Chief Compliance OfficerN/AN/AN/A
Mr. Michael V. Williamson Esq., J.D.Sr. VP, Gen. & IP CounselN/AN/A1972
Dr. Karen L. Noblett M.A.S., M.D.Chief Medical OfficerN/AN/A1964
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Corporate Governance

Axonics, Inc.’s ISS Governance QualityScore as of July 1, 2022 is 4. The pillar scores are Audit: 10; Board: 5; Shareholder Rights: 4; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement